Javier García Corbacho (J Garcia-Corbacho, Javier García-Corbacho, Javier Garcia-Corbacho, Javier García-Carbacho, Javier Garciá Corbacho)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Metastatic Breast Cancer

Top Venues

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study. Cancer research communications (2024)
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study. Cancer research communications 4 (6) (2024)
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study. Cancer research communications 4 (6) (2024)
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study. Cancer research communications 4 (6) (2024)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, V Ferguson, Michael J Seckl
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 14 (1) (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, V Ferguson, Michael J Seckl
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 14 (1) (2023)
David Pesántez, Alberto Indacochea, Laura Angelats, Marianna Sirico, Iván Victoria, Esther Sanfeliu, Cristina Teixidó, Azucena E González-Navarro, Patricia Galván, Fara Brasó-Maristany, Pedro Jares, Manel Juan, Aleix Prat, Francesco Schettini, Javier García Corbacho
Unexpected Durable Complete Response With Anti-PD-L1 Blockade in Metastatic Undifferentiated Pleomorphic Sarcoma: A Case Report With Host and Tumor Biomarker Analysis. JCO precision oncology 7 (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, Michael J Seckl
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 13 (1) (2022)
Aleix Prat, Luis G Paz-Ares, Manel Juan, Enriqueta Felip Font, Elena Garralda, Blanca Gonzalez-Farre, Ana M Arance, Juan Martín-Liberal, Joaquín Gavilá, Ana López-González, Juan Miguel Cejalvo, Yann Izarzugaza, Kepa Amillano, Javier García Corbacho, Cristina Saura, Fabricio Racca, Cinta Hierro, Esther Sanfeliu, Xavier Gonzalez, Jordi Canes, Guillermo Villacampa, Fernando Salvador, Tomás Pascual, Ricard Mesía, Andres Cervantes, Josep Tabernero
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA. Future oncology (London, England) (2022)
Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, Alexander Spira, Funda Meric-Bernstam, Nataliya Uboha, Rachel E Sanborn, Randy F Sweis, Patricia LoRusso, Misako Nagasaka, Javier García Corbacho, Shadia Jalal, James J Harding, Stella K Kim, Iris H C Miedema, Danielle J Vugts, Marc C Huisman, Gerben J C Zwezerijnen, Guus A M S van Dongen, Catharina Willemien Menke-van der Houven van Oordt, Song Wang, Tam Dang, Ivan A Zein, Olga Vasiljeva, Susan K Lyman, Virginia Paton, Alison Hannah, Joyce F Liu
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Atish D Choudhury, Celestia S Higano, Johann S de Bono, Natalie Cook, Dana E Rathkopf, Kari B Wisinski, Juan Martin-Liberal, Mark Linch, Elisabeth I Heath, Richard D Baird, Javier García Corbacho, Miguel Quintela-Fandino, Simon T Barry, Elza C de Bruin, Steve Colebrook, George Hawkins, Teresa Klinowska, Brijesh Maroj, Ganesh Moorthy, Peter G S Mortimer, Michele Moschetta, Myria Nikolaou, Liz Sainsbury, Geoffrey I Shapiro, Lillian L Siu, Aaron Richard Hansen
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Melissa Johnson, Anthony El-Khoueiry, Navid Hafez, Nehal Lakhani, Hirva Mamdani, Jordi Rodon, Rachel E Sanborn, Javier García Corbacho, Valentina Boni, Mark Stroh, Alison L Hannah, Song Wang, Henry Castro, Alexander Spira
Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)